These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

440 related articles for article (PubMed ID: 29797744)

  • 21. Mapping the order and pattern of brain structural MRI changes using change-point analysis in premanifest Huntington's disease.
    Wu D; Faria AV; Younes L; Mori S; Brown T; Johnson H; Paulsen JS; Ross CA; Miller MI;
    Hum Brain Mapp; 2017 Oct; 38(10):5035-5050. PubMed ID: 28657159
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vivo characterization of white matter pathology in premanifest huntington's disease.
    Zhang J; Gregory S; Scahill RI; Durr A; Thomas DL; Lehericy S; Rees G; Tabrizi SJ; Zhang H;
    Ann Neurol; 2018 Oct; 84(4):497-504. PubMed ID: 30063250
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diffusion tensor imaging in presymptomatic and early Huntington's disease: Selective white matter pathology and its relationship to clinical measures.
    Rosas HD; Tuch DS; Hevelone ND; Zaleta AK; Vangel M; Hersch SM; Salat DH
    Mov Disord; 2006 Sep; 21(9):1317-25. PubMed ID: 16755582
    [TBL] [Abstract][Full Text] [Related]  

  • 24. White and Gray Matter Abnormalities in Manifest Huntington's Disease: Cross-Sectional and Longitudinal Analysis.
    Sweidan W; Bao F; Bozorgzad NS; George E
    J Neuroimaging; 2020 May; 30(3):351-358. PubMed ID: 32128927
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Onset and rate of striatal atrophy in preclinical Huntington disease.
    Aylward EH; Sparks BF; Field KM; Yallapragada V; Shpritz BD; Rosenblatt A; Brandt J; Gourley LM; Liang K; Zhou H; Margolis RL; Ross CA
    Neurology; 2004 Jul; 63(1):66-72. PubMed ID: 15249612
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Progression of structural neuropathology in preclinical Huntington's disease: a tensor based morphometry study.
    Kipps CM; Duggins AJ; Mahant N; Gomes L; Ashburner J; McCusker EA
    J Neurol Neurosurg Psychiatry; 2005 May; 76(5):650-5. PubMed ID: 15834021
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Regional white matter change in pre-symptomatic Huntington's disease: a diffusion tensor imaging study.
    Reading SA; Yassa MA; Bakker A; Dziorny AC; Gourley LM; Yallapragada V; Rosenblatt A; Margolis RL; Aylward EH; Brandt J; Mori S; van Zijl P; Bassett SS; Ross CA
    Psychiatry Res; 2005 Oct; 140(1):55-62. PubMed ID: 16199141
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Striatal and extrastriatal atrophy in Huntington's disease and its relationship with length of the CAG repeat.
    Ruocco HH; Lopes-Cendes I; Li LM; Santos-Silva M; Cendes F
    Braz J Med Biol Res; 2006 Aug; 39(8):1129-36. PubMed ID: 16906288
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Timing of selective basal ganglia white matter loss in premanifest Huntington's disease.
    Zeun P; McColgan P; Dhollander T; Gregory S; Johnson EB; Papoutsi M; Nair A; Scahill RI; Rees G; Tabrizi SJ;
    Neuroimage Clin; 2022; 33():102927. PubMed ID: 34999565
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A longitudinal diffusion tensor imaging study in symptomatic Huntington's disease.
    Sritharan A; Egan GF; Johnston L; Horne M; Bradshaw JL; Bohanna I; Asadi H; Cunnington R; Churchyard AJ; Chua P; Farrow M; Georgiou-Karistianis N
    J Neurol Neurosurg Psychiatry; 2010 Mar; 81(3):257-62. PubMed ID: 19237387
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Natural biological variation of white matter microstructure is accentuated in Huntington's disease.
    Gregory S; Crawford H; Seunarine K; Leavitt B; Durr A; Roos RAC; Scahill RI; Tabrizi SJ; Rees G; Langbehn D; Orth M
    Hum Brain Mapp; 2018 Sep; 39(9):3516-3527. PubMed ID: 29682858
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Apathy Is Related to Cognitive Control and Striatum Volumes in Prodromal Huntington's Disease.
    Misiura MB; Ciarochi J; Vaidya J; Bockholt J; Johnson HJ; Calhoun VD; Paulsen JS; Turner JA;
    J Int Neuropsychol Soc; 2019 May; 25(5):462-469. PubMed ID: 30806337
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Longitudinal Diffusion Tensor Imaging Shows Progressive Changes in White Matter in Huntington's Disease.
    Gregory S; Cole JH; Farmer RE; Rees EM; Roos RA; Sprengelmeyer R; Durr A; Landwehrmeyer B; Zhang H; Scahill RI; Tabrizi SJ; Frost C; Hobbs NZ
    J Huntingtons Dis; 2015; 4(4):333-46. PubMed ID: 26756590
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Developmental Whole Brain White Matter Alterations in Transgenic Huntington's Disease Monkey.
    Meng Y; Jiang J; Bachevalier J; Zhang X; Chan AW
    Sci Rep; 2017 Mar; 7(1):379. PubMed ID: 28336929
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Executive dysfunction in early stages of Huntington's disease is associated with striatal and insular atrophy: a neuropsychological and voxel-based morphometric study.
    Peinemann A; Schuller S; Pohl C; Jahn T; Weindl A; Kassubek J
    J Neurol Sci; 2005 Dec; 239(1):11-9. PubMed ID: 16185716
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impaired cortico-striatal functional connectivity in prodromal Huntington's Disease.
    Unschuld PG; Joel SE; Liu X; Shanahan M; Margolis RL; Biglan KM; Bassett SS; Schretlen DJ; Redgrave GW; van Zijl PC; Pekar JJ; Ross CA
    Neurosci Lett; 2012 Apr; 514(2):204-9. PubMed ID: 22425717
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cross-sectional and longitudinal multimodal structural imaging in prodromal Huntington's disease.
    Harrington DL; Long JD; Durgerian S; Mourany L; Koenig K; Bonner-Jackson A; Paulsen JS; ; Rao SM
    Mov Disord; 2016 Nov; 31(11):1664-1675. PubMed ID: 27620011
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Microstructural brain abnormalities in Huntington's disease: A two-year follow-up.
    Odish OF; Leemans A; Reijntjes RH; van den Bogaard SJ; Dumas EM; Wolterbeek R; Tax CM; Kuijf HJ; Vincken KL; van der Grond J; Roos RA
    Hum Brain Mapp; 2015 Jun; 36(6):2061-74. PubMed ID: 25644819
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Specific patterns of brain alterations underlie distinct clinical profiles in Huntington's disease.
    Garcia-Gorro C; Llera A; Martinez-Horta S; Perez-Perez J; Kulisevsky J; Rodriguez-Dechicha N; Vaquer I; Subira S; Calopa M; Muñoz E; Santacruz P; Ruiz-Idiago J; Mareca C; Beckmann CF; de Diego-Balaguer R; Camara E
    Neuroimage Clin; 2019; 23():101900. PubMed ID: 31255947
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Topography of cerebral atrophy in early Huntington's disease: a voxel based morphometric MRI study.
    Kassubek J; Juengling FD; Kioschies T; Henkel K; Karitzky J; Kramer B; Ecker D; Andrich J; Saft C; Kraus P; Aschoff AJ; Ludolph AC; Landwehrmeyer GB
    J Neurol Neurosurg Psychiatry; 2004 Feb; 75(2):213-20. PubMed ID: 14742591
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.